STEOVESS alendronic acid (as sodium) 70mg effervescent tablet blister pack

País: Australia

Idioma: inglés

Fuente: Department of Health (Therapeutic Goods Administration)

Ingredientes activos:

alendronate sodium, Quantity: 91.37 mg (Equivalent: alendronic acid, Qty 70 mg)

Disponible desde:

Pharmbio Pty Ltd

Designación común internacional (DCI):

alendronate sodium

formulario farmacéutico:

Tablet, effervescent

Composición:

Excipient Ingredients: monosodium dihydrogen citrate; citric acid; sodium bicarbonate; sodium carbonate; acesulfame potassium; sucralose; Flavour

Vía de administración:

Oral

Unidades en paquete:

4, 1, 2

tipo de receta:

(S4) Prescription Only Medicine

indicaciones terapéuticas:

Steovess is indicated for the treatment of osteoporosis. Prior to treatment, osteoporosis must be confirmed by the finding of low bone mass of at least 2 standard deviations below the gender specific mean for young adults or by the presence of osteoporotic fracture

Resumen del producto:

Visual Identification: White to off-white round, flat tablet with bevelled edges; Container Type: Blister Pack; Container Material: Other composite material; Container Life Time: 2 Years; Container Temperature: Store below 30 degrees Celsius

Estado de Autorización:

Licence status A

Fecha de autorización:

2012-06-18